TCRT

Alaunos Therapeutics, Inc. Common Stock

$2.87 +0.70%

Recent alerts on TCRT

All signals →

SEC filing TCRT Reports Positive Preclinical ALN1003 Data, Shows 12.9% Body Weight Reduction, Improved Insulin Sensitivity, and Enhanced Liver Health in Obese Mouse Studies

SEC filing TCRT Delisted from Nasdaq Capital Market, $2.15M Equity Below $2.5M Minimum, 45-Day Plan Required, May Face Hearing

SEC filing TCRT Announces Positive Preclinical Data for ALN1003 Obesity Drug, Shows 12.9% Weight Loss, Liver Reduction

News Philip Morris targets 5–7% organic net revenue growth for 2026 while expanding smoke-free leadership

News Philip Morris Beats Estimates as Smoke-Free Products Drive Earnings Momentum

News Philip Morris (PM) Q4 2025 Earnings Transcript

News Philip Morris lifts profit outlook on smoke-free growth but underwhelms in Q4

News Philip Morris Posts Higher Profit, Revenue; Forecasts Continued Growth

News Earnings Snapshot: Philip Morris forecasts 2026 EPS of $7.87–$8.02; organic revenue growth seen at 5%–7%

News Philip Morris in charts: Q4 sees smoke-free revenues up ~13% Y/Y

Scanner Unusual volume (3.3x average)

Get push alerts for TCRT

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS